Penny Wright1, Laura Marshall, Adam B Smith, Galina Velikova, Peter Selby. 1. Psychosocial and Clinical Practice Research Group, Cancer Research UK Clinical Centre, Section of Oncology and Clinical Research, University of Leeds, St James's University Hospital, Beckett Street, Leeds LS9 7TF, United Kingdom. e.p.wright@leeds.ac.uk
Abstract
UNLABELLED: Cancer has a significant social impact. There is a requirement to undertake formal assessment of this in research and clinical practice. AIM: To establish values of clinically meaningful differences and changes in social distress (SOCD) using the social difficulties inventory (SDI). METHODS: Newly diagnosed patients treated with curative intent completed the SDI and the EORTC quality of life questionnaire (EORTC QLQ-C30) at baseline, 6, 12 and 24 months. Minimally important differences (MIDs) were estimated using anchor and distribution methods. RESULTS: One hundred and eighty-eight patients participated. SOCD was elevated at baseline demonstrating the social burden of cancer on patients following diagnosis. Anchor estimates for MIDs were by age groups 3.37 and in comparison to EORTC QLQ-C30 social functioning scale from 0 to 6.27. Using distribution methods: SEM 2.01-4.92 and SD 1.67-3.57. CONCLUSION: For general guidance, an estimate of 3 (range 0-44) is recommended as a clinically important difference, illustrated by case studies and group comparisons.
UNLABELLED: Cancer has a significant social impact. There is a requirement to undertake formal assessment of this in research and clinical practice. AIM: To establish values of clinically meaningful differences and changes in social distress (SOCD) using the social difficulties inventory (SDI). METHODS: Newly diagnosed patients treated with curative intent completed the SDI and the EORTC quality of life questionnaire (EORTC QLQ-C30) at baseline, 6, 12 and 24 months. Minimally important differences (MIDs) were estimated using anchor and distribution methods. RESULTS: One hundred and eighty-eight patients participated. SOCD was elevated at baseline demonstrating the social burden of cancer on patients following diagnosis. Anchor estimates for MIDs were by age groups 3.37 and in comparison to EORTC QLQ-C30 social functioning scale from 0 to 6.27. Using distribution methods: SEM 2.01-4.92 and SD 1.67-3.57. CONCLUSION: For general guidance, an estimate of 3 (range 0-44) is recommended as a clinically important difference, illustrated by case studies and group comparisons.
Authors: Naheed Hanif; Nimarta Dharni; Adam Smith; Sangeeta Chattoo; Galina Velikova; Chris Bradley; Dan Stark; Penny Wright Journal: Qual Life Res Date: 2010-10-15 Impact factor: 4.147
Authors: Emma J Podmore; Laura C Bingham; Kathryn M Roberts; Peter J Selby; Penny Wright; Galina Velikova Journal: Support Care Cancer Date: 2009-07-11 Impact factor: 3.603
Authors: Maria J Santana; Lotte Haverman; Kate Absolom; Elena Takeuchi; David Feeny; Martha Grootenhuis; Galina Velikova Journal: Qual Life Res Date: 2015-01-15 Impact factor: 4.147
Authors: Valerie Shilling; Rachel Starkings; Valerie Jenkins; David Cella; Lesley Fallowfield Journal: Qual Life Res Date: 2018-07-26 Impact factor: 4.147
Authors: Ahmad Ousmen; Célia Touraine; Nina Deliu; Francesco Cottone; Franck Bonnetain; Fabio Efficace; Anne Brédart; Caroline Mollevi; Amélie Anota Journal: Health Qual Life Outcomes Date: 2018-12-11 Impact factor: 3.186
Authors: Samantha J Mason; Amy Downing; Penny Wright; Luke Hounsome; Sarah E Bottomley; Jessica Corner; Mike Richards; James W Catto; Adam W Glaser Journal: Br J Cancer Date: 2018-05-14 Impact factor: 7.640